SK Bioscience, which has signed a CMO deal to manufacture the Novavax vaccine, has additional received EU-GMP certification from the European Medicines Agency. This is the third EU-GMP certification the company received.

On the 25th, SK Bioscience announced that it had received additional EU-GMP certification for the manufacturing facility, process, and quality system of Andong L House that is being operated for the manufacture of the Novavax COVID-19 vaccine. SK Bioscience has been producing the drug substance of Novavax’s COVID-19 vaccine under a CMO (contract manufacturing organization) deal.

With the approval, SK Bioscience’s L House received the third EU-GMP approval as a vaccine